Skip to main content
Caplight Logo









Enginprime Medical

Enginprime Medical

Private
HangzhouHealthcare & Life Scienceshttps://enginprime.com

Last Round

Series A

Aug 18, 2026

Total Funding Raised

$12M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Enginprime Medical is a medical device company that develops next-generation percutaneous ventricular assist device (pVAD) technology for temporary circulatory support.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

percutaneous ventricular assist devicepVADmechanical circulatory supportcardiovascular medical deviceinterventional cardiologyhemodynamic supportCHIP PCIheart pumphigh-risk cardiac interventioncardiac assist devicemedical device R&Dcatheter technologytemporary heart support

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Enginprime Medical Comparables

Compare Enginprime Medical with similar companies based on industry and business-model similarity.

Enginprime Medical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Puzzle Medical Devices Inc.
85%
Magenta Medical
84%
Narwhal Medical
84%

Enginprime Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AAug 18, 2026

Enginprime Medical Investors

Notable investors and investment history

Enginprime Medical investors
InvestorRounds
Qiming Venture PartnersSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 18, 2026

    $12M round led by Qiming Venture Partners.

Recent news

Latest coverage and updates

  • is_developingAug 18, 2026

    Enginprime Medical Inc is developing next-generation percutaneous ventricular assist systems on Aug 18th '26.

  • receives_financingAug 18, 2026

    Enginprime Medical Inc received financing of $12M in Series A on Aug 18th '26.

Enginprime Medical Filings

Explore SEC and related filing metadata, where available.

Enginprime Medical filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Enginprime Medical's valuation, stock price, and market status.

Is Enginprime Medical a public or private company?

Enginprime Medical is a private company.

What is the current stock price of Enginprime Medical?

Enginprime Medical is a private company with no public stock price. Caplight tracks Enginprime Medical's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Enginprime Medical worth (valuation)?

Valuation information for Enginprime Medical is not publicly available.

Can I buy Enginprime Medical stock?

Enginprime Medical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Enginprime Medical's last funding round?

Enginprime Medical's most recent funding round was Series A on August 18, 2026.

Who are the main investors in Enginprime Medical?

Key investors in Enginprime Medical include Qiming Venture Partners.

Will Enginprime Medical IPO soon?

No public IPO plans have been announced for Enginprime Medical.

How can I track Enginprime Medical secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Enginprime Medical's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersHangzhou
Year Founded2023
Last FundingAug 18, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?